Impact of GGCX Polymorphisms on Warfarin Doserequirements in Atrial Fibrillation Patients

Turkish Journal of Medical Sciences - Turkey
doi 10.3906/sag-1609-26
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

The Scientific and Technological Research Council of Turkey

Related search

Warfarin Versus Warfarin and Aspirin in Atrial Fibrillation

Neurological Bulletin
2011English

Erratum To: Effect of VKORC1, CYP2C9, CYP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients

Molecular Diagnosis and Therapy
MedicineMolecular MedicineGeneticsPharmacology
2016English

Anticoagulation in Patients With Atrial Fibrillation. Underuse of Warfarin Is Multifactorial.

BMJ
1993English

Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Yearbook of Cardiology
2012English

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

PCV79 Compliance With Warfarin Therapy by Australian Patients With Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Under-Use of Warfarin for Patients With Non-Valvular Atrial Fibrillation in Japan

Internal Medicine
Internal MedicineMedicine
2004English

Effect of Ximelagatran and Warfarin on Stroke Subtypes in Atrial Fibrillation

Canadian Journal of Neurological Sciences
MedicineNeurology
2008English

Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation

Archives of Internal Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy